Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Translin-associated factor X pseudogene (ENSG00000256221) is a nonfunctional copy of the gene encoding translin-associated factor X (TSNAX/TRAX). Pseudogenes like this are stretches of DNA with high sequence similarity to their parent genes but are unable to produce a functional protein due to disabling mutations such as frameshifts or premature stop codons[1][3]. While some pseudogenes may occasionally be transcribed or have regulatory roles, the majority—including this one—do not participate in cellular functions or drug interactions and are generally not considered therapeutic targets. The entry is distinct from the functional TSNAX/TRAX gene, which encodes a protein involved in microRNA degradation, synaptic plasticity, and DNA repair[2][6]. Key point: If you are seeking therapeutic or biological target information, the correct entry is the functional "Translin-associated factor X" (TSNAX/TRAX), not this pseudogene.
None (pseudogenes are not known drug targets, so mechanisms do not apply)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Translin-associated factor X pseudogene (None).